Procept Biorobotics Corp expected to post a loss of 44 cents a share - Earnings Preview

PROCEPT BioRobotics

24/02/2024 03:05

* Procept Biorobotics Corp  PRCT.OQ   PRCT.O  is expected
to show
a rise in quarterly revenue when it reports  results on February
27 for the period ending December 31 2023
    * The San Jose California-based  company is expected to
report a
76.9% increase in revenue to $42.062 million from $23.78 million
a year ago, according to the mean estimate from 9 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Procept Biorobotics Corp
is
for a loss of 44 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Procept
Biorobotics Corp is $50.00​, above​ its last closing price
of $48.83. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.51       -0.51      -0.51     Met     0.9
 Jun. 30 2023  -0.57       -0.57      -0.56     Beat    2
 Mar. 31 2023  -0.58       -0.58      -0.63     Missed  -8.4​
 Dec. 31 2022  -0.55       -0.54      -0.56     Missed  -2.9
 ​​Sep.        -0.48       -0.48      -0.51     Missed  -6
 30 2022                                                
 Jun. 30 2022  -0.48       -0.48      -0.43     Beat    10.8​
 Mar. 31 2022  -0.48       -0.47      -0.39     Beat    17.5
 Dec. 31 2021  -0.41       -0.39      -0.42     Missed  -7.7
 This summary was machine generated February 24 at 03:05 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)